Regulacje i polityka gospodarcza · 29/10/2002

National Institutes of Health to Grant Exclusive License for Mesothelin Patent to Cell Genesys, Inc.

The National Institutes of Health is considering granting an exclusive license to Cell Genesys, Inc. to practice patents related to mesothelin, a differentiation antigen present in mesothelium, mesotheliomas, and ovarian cancers, for use in human gene therapy to treat cancer.

Source: Federal Register — All DocumentsOpen original release →

Find a company or service

Business Communicator helps companies present their offer, publish updates and connect directly.

Create a company profile Explore businesses on Business Maps →

LATEST SIGNALS

Regulacje i polityka gospodarcza · 10/14/2026

Department of War Requests Comments on Proposed Manual for Courts-Martial Amendments

The Department of War (DoW) is seeking comments on proposed changes to the Manual for Courts-Martial (MCM) and has announced a public meeting to receive comments on the changes.

Read summary →